12:00 AM
 | 
Nov 10, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Tamatinib fosdium: Phase II delayed

Rigel said it will delay the start of any further trials of R788 for idiopathic thrombocytopenic purpura (ITP) and lupus until it finds a partner...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >